Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27420079 | 0.86 | MEN1 (0.44) | MEN1KMT2AARACACBPDE4B | |
| SCHEMBL27419889 | 0.75 | MEN1 (0.42) | MEN1KMT2AARACACBSLC6A4 | |
| SCHEMBL27419900 | 0.75 | MEN1 (0.42) | MEN1KMT2AARACACBSLC6A4 | |
| SCHEMBL27419914 | 0.70 | GAA (0.44) | — | |
| SCHEMBL4507930 | 0.69 | GAA (0.47) | MEN1KMT2A | |
| SCHEMBL27419986 | 0.68 | GAA (0.46) | — | |
| SCHEMBL27419994 | 0.66 | KDM1A (0.44) | MEN1KMT2ASLC6A4SLC6A3PDE4B | |
| SCHEMBL27420721 | 0.65 | KMT2A (0.35) | KMT2A | |
| SCHEMBL27419842 | 0.65 | MEN1 (0.46) | MEN1KMT2AACACBSLC6A4SLC6A3 | |
| SCHEMBL4139034 | 0.64 | SLC6A4 (0.48) | SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024092256-A2 | PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-05-02 | — | — | WO | disclosed |